Market Overview According to the research report, the global Ebola Vaccines market was valued at USD 6.64 million in 2022 and is expected to reach USD 110.46 million by 2032, to grow at a CAGR of 32.5% during the forecast period. Ebola virus disease (EVD), caused by infection with viruses within the Ebolavirus genus, remains one of the most dangerous viral diseases due to...